Carolina S Vieira
Professor · University of Sao Paulo · Sao Paulo University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Carolina S Vieira as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:04 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT04047875 · Treatment of Prolonged Uterine Bleeding of Etonogestrel (ENG)-Releasing ImplantUniversity of Sao Paulo · completed · Breakthrough Bleeding · study chair
- Ph4NCT03307863 · Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With EpilepsyUniversity of Sao Paulo · suspended · Contraception, Drug Interactions · principal investigator
- Ph4NCT03111342 · Intracervical Anesthesia and Pain Associated With Intrauterine Contraceptive InsertionUniversity of Sao Paulo · completed · Pain, Acute, Anesthesia, Local, IUD Insertion Complication · principal investigator
- Ph4NCT02469454 · Effect of t of the Etonogestrel Releasing Implant on Infant Growth and DevelopmentUniversity of Sao Paulo · completed · Contraception, Newborn, Child Development · principal investigator
- Ph4NCT02416687 · Etonogestrel Implant and Postpartum InsertionUniversity of Sao Paulo · completed · Contraception · principal investigator
- Ph4NCT02342093 · Contraceptives Containing Drospirenone and Blood PressureUniversity of Sao Paulo · completed · Blood Pressure, Contraception · principal investigator
- Ph4NCT02158845 · Levonorgestrel-releasing Intrauterine System in Patients With EndometriosisUniversity of Sao Paulo · completed · Endometriosis · principal investigator
- N/ANCT02155166 · Effect of Intracervical on the Pain Associated With the Insertion of the LNG-IUSUniversity of Sao Paulo · completed · Pain · principal investigator
- N/ANCT00842140 · Safety of Hormonal Contraceptives Therapies in Polycystic Ovary Syndrome (PCOS) WomenUniversity of Sao Paulo · completed · Polycystic Ovary Syndrome · principal investigator
- N/ANCT00828542 · Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy WomenUniversity of Sao Paulo · completed · Breastfeeding, Contraception · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:04 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 11:04 UTC. The ranking covers the 200 most relevant of 31 PubMed records, and a shared surname and initials can bring in a namesake. All 31 on PubMed
- Safety of the etonogestrel-releasing implant during the immediate postpartum period: a pilot study.Contraception · 200965 citationsRCR 2.8
- Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women.J Acquir Immune Defic Syndr · 201461 citationsRCR 2.7
- 44 citationsRCR 1.6
- Effects of the levonorgestrel-releasing intrauterine system on cardiovascular risk markers in patients with endometriosis: a comparative study with the GnRH analogue.Contraception · 201043 citationsRCR 1.6
- Immediate postpartum initiation of etonogestrel-releasing implant: A randomized controlled trial on breastfeeding impact.Contraception · 201537 citationsRCR 2.1
- PRENACEL - a mHealth messaging system to complement antenatal care: a cluster randomized trial.Reprod Health · 201737 citationsRCR 2.3
- 36 citationsRCR 1.6
- The levonorgestrel-releasing intrauterine system and endometriosis staging.Fertil Steril · 200728 citationsRCR 1.1
- The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome.Contraception · 201222 citationsRCR 0.9
- Effects of combined oral contraceptives containing levonorgestrel or chlormadinone on the endothelium.Contraception · 201322 citationsRCR 1.0